| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 10/06/2010 | EP2235007A1 6h-dibenz0 [b, e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists |
| 10/06/2010 | CN101855234A Preparation of 6-oxa-8alpha-steroid estrogen analogues - a new group of unnatural estrogens and their use in medicine |
| 10/06/2010 | CN101854952A Isoflavone formulation |
| 10/06/2010 | CN101851288A Analogs of parathyroid hormone |
| 10/06/2010 | CN101851238A Substituted 8-heteroaryl xanthines |
| 10/06/2010 | CN101849924A Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 10/05/2010 | US7807688 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders |
| 10/05/2010 | US7807659 5-Fluoro-4-oxo-3-[1-(substituted-carbonyl)-2-piperidinecarboxamido]-pentanoic acid derivatives such as [3S/R (2S)]-5-Fluoro-4-oxo-3-[1-(2-phenyl-thiazole-4-carbonyl)-2-piperidinecarboxamido]-pentanoic acid, used for the treatment of bone disorders, inflammatory, autoimmune and degenerative diseases |
| 10/05/2010 | US7807170 Modulating an immune response in a subject by administering an effective amount of a lymphocyte differentiation factor; antiinflammatory agents |
| 09/30/2010 | WO2010110689A1 A novel medical use of kynurenic acid, its precursors and derivatives |
| 09/30/2010 | WO2010110639A1 A phytoestrogenic nutraceutical composition from palm leaf extract |
| 09/30/2010 | WO2010110479A1 Activator for peroxisome proliferator-activated receptor |
| 09/30/2010 | WO2010110440A1 Novel therapeutic agent for cognitive impairment |
| 09/30/2010 | US20100249224 Methods and compositions for modulating glutamate dehydrogenase |
| 09/30/2010 | US20100249163 Renin inhibitors |
| 09/30/2010 | US20100249137 Novel sEH Inhibitors and Their Use |
| 09/30/2010 | US20100249083 16,17-carbocyclic condensed steroid compounds having selective estrogenic activity |
| 09/30/2010 | US20100249049 Arylalkylamine compound and process for preparing the same |
| 09/30/2010 | US20100249046 Novel mangiferin calcium salts, the method for its preparation and its use |
| 09/30/2010 | US20100249032 Human EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses |
| 09/30/2010 | US20100249026 Albumin fusion proteins |
| 09/30/2010 | US20100247688 Pirenzepine and derivatives thereof as anti-amyloid agents |
| 09/30/2010 | US20100247661 Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces |
| 09/30/2010 | US20100247625 Orally Bioavailable Lipid-Based Constructs |
| 09/30/2010 | US20100247608 Pharmaceutical compositions comprising hgh for oral delivery |
| 09/30/2010 | US20100247594 Delivery of dry formulations of octreotide |
| 09/30/2010 | US20100247518 Modified proteins, designer toxins, and methods of making thereof |
| 09/30/2010 | US20100247482 Tight junction modulator peptides for enhanced mucosal delivery of therapeutic compounds |
| 09/30/2010 | CA2754416A1 Novel medicament for treating cognitive impairment |
| 09/29/2010 | EP2233141A1 Ppharmaceutical compositions coprising polymorphic forms of dehydroepiandrosterone |
| 09/29/2010 | EP2231646A1 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists |
| 09/29/2010 | EP2231197A2 Methods of generating expanded and re-differentiated adult islet beta cells for use in the treatment of diabetes |
| 09/29/2010 | EP2231128A1 Method of treating dysglycemia and glucose excursions |
| 09/29/2010 | CN1927403B Medicine for promoting pigling growth and improving pigling immunity and preparing method thereof |
| 09/29/2010 | CN1893963B Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 09/29/2010 | CN101843842A Medicament for treating hypothyroidism |
| 09/29/2010 | CN101081203B Hydrogel, alcogel pharmaceutical uses |
| 09/28/2010 | US7803840 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 09/28/2010 | US7803772 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity |
| 09/28/2010 | US7803749 Prevent signal transduction passageways; kinase inhibitor; modulate immunology response |
| 09/28/2010 | US7803381 Synthetic peptide comprising the amino acid sequence GPRLGYSWHX in which each of the amino acids are in the D-amino acid configuration and X is any amino acid; optionally conjugated to the natural gonadotropin-releasing hormone peptide; vaccines for use incontrolling fertility or heat in an animal |
| 09/28/2010 | CA2570047C 4-cycloalkoxy benzonitriles as androgen modulators |
| 09/28/2010 | CA2430366C Improved oral delivery of peptides using enzyme-cleavable membrane translocators |
| 09/23/2010 | WO2010108107A1 Polymorphs of fluticasone furoate and processes for preparation thereof |
| 09/23/2010 | WO2010106383A1 Novel crystalline form of antiprogestin cdb-4124 |
| 09/23/2010 | US20100240866 Modified gherlin peptides |
| 09/23/2010 | US20100240724 Edible Film |
| 09/23/2010 | US20100240641 Aldosterone Synthase and/or 11B-hydroxylase Inhibitors |
| 09/23/2010 | US20100240631 Pharmaceutical composition for the sublingual administration of progesterone, and method for its preparation |
| 09/23/2010 | US20100240620 3-Cyano-5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases |
| 09/23/2010 | US20100240581 Selective proteasome inhibitors for treating diabetes |
| 09/23/2010 | US20100240580 Azoloarine derivatives, method for the production thereof, pharmaceuticals containing these compounds and the use thereof |
| 09/23/2010 | US20100239685 Compound for treatment or prevention of prostate-related diseases and pharmaceutical composition of colon delivery system containing the same |
| 09/23/2010 | US20100239683 Sustained release of microcrystalline peptide suspensions |
| 09/23/2010 | US20100239676 Stable Aerosolizable Suspensions of Proteins in Ethanol |
| 09/23/2010 | US20100239666 Process for producing mouldings from (meth) acrylate copolymers by means of injection moulding |
| 09/23/2010 | US20100239554 Extended recombinant polypeptides and compositions comprising same |
| 09/23/2010 | US20100239520 Organic compounds |
| 09/23/2010 | DE212008000064U1 Vorrichtung zur Überwachung der Diabetes-Insulin-Therapie Apparatus for monitoring the Diabetes Insulin therapy |
| 09/23/2010 | DE102009013642A1 Substituierte Phenylalaninderivate und deren Verwendung Substituted phenylalanine derivatives and the use thereof |
| 09/22/2010 | EP2230241A1 Tetrahydro-imidazoý1,5-a¨pyrazine derivatives, preparation methods and medical uses thereof |
| 09/22/2010 | EP1809271B9 Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 09/22/2010 | CN1976705B 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1H-pyrrolo not 2,3-C|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and dia |
| 09/22/2010 | CN101842083A LH liquid formulations |
| 09/22/2010 | CN101838327A Human IL-15 subtype protein and preparation method and application thereof |
| 09/22/2010 | CN101838239A Pyrazole compound as well as composition and application thereof |
| 09/22/2010 | CN101837057A Components of compound formula of Chinese medicament active parts, preparation process thereof and anti-diabetic use thereof |
| 09/22/2010 | CN101837034A Method for extracting radix achyranthis bidentatae saponin |
| 09/21/2010 | US7799771 solid dosage form for contraceptives and hormone replacement therapy; very low moisture content to prevent ester hydrolysis; enhanced bioavailability of 17-beta-estradiol acetate; FDA Orange book listed patent for estradiol acetate |
| 09/21/2010 | US7799770 For use in female birth control, for therapy of hormone-dependent gynecological disorders and for hormone replacement therapy |
| 09/21/2010 | CA2458415C 24-sulfur-substituted analogs of 1.alpha.,25-dihydroxy vitamin d3 |
| 09/21/2010 | CA2449521C Pharmaceutical formulation, its use, and method for its manufacture |
| 09/21/2010 | CA2428019C Estrogen receptor modulators |
| 09/21/2010 | CA2408746C Antisense phosporodiamidate morpholino oligonucleotide inhibition of cytochrome p450 to modulate drug pharmacokinetics |
| 09/16/2010 | WO2010104721A1 Mineralocorticoid receptor antagonist and methods of use |
| 09/16/2010 | WO2010103045A1 Treatment of diabetes and metabolic syndrome |
| 09/16/2010 | WO2010102554A1 New crystalline form vi of agomelatine, preparation method and application thereof |
| 09/16/2010 | WO2010054286A3 Substituted hydroxyphenylamine compounds |
| 09/16/2010 | WO2010052563A3 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof |
| 09/16/2010 | US20100234353 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 09/16/2010 | US20100234344 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators |
| 09/16/2010 | US20100234334 Nitric oxide releasing steroids |
| 09/16/2010 | US20100234330 Novel Estrogenic Compounds |
| 09/16/2010 | US20100234305 Polymeric delivery formulations of leuprolide with improved efficacy |
| 09/16/2010 | US20100233264 TEMPERATURE AND pH-SENSITIVE BLOCK COPOLYMER HAVING EXCELLENT SAFTY IN VIVO AND HYDROGEL AND DRUG DELIVERY SYSTEM USING THEREOF |
| 09/16/2010 | US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides |
| 09/16/2010 | US20100233153 Novel gene disruptions, compositions and the methods relating thereto |
| 09/16/2010 | US20100233079 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 09/16/2010 | CA2755068A1 Treatment of diabetes and metabolic syndrome |
| 09/16/2010 | CA2754276A1 New crystalline form vi of agomelatine, preparation method and application thereof |
| 09/16/2010 | CA2751901A1 Mineralocorticoid receptor antagonist and methods of use |
| 09/15/2010 | EP2228375A1 New xanthin derivatives, their production and utilisation as medicine |
| 09/15/2010 | EP2228364A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 09/15/2010 | EP2227490A2 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases |
| 09/15/2010 | EP2227450A2 Selective estrogen receptor modulator compositions and methods for treatment of disease |
| 09/15/2010 | EP1501819B1 Estrogen receptor modulators |
| 09/15/2010 | EP1303596B1 Morpholino antisense oligomers as enzyme inhibitors for improving pharmacokinetics of a drug |
| 09/15/2010 | CN101835763A Oxadiazolidinedione compound |
| 09/15/2010 | CN101835747A Benzimidazole derivative |
| 09/15/2010 | CN101830889A 嘧啶衍生物 Pyrimidine derivatives |